Supernus Pharmaceuticals | SUPN - Trade Creditors

Stock Price
56.04
Daily Change
2.74 5.14%
Monthly
14.00%
Yearly
75.62%
Q1 Forecast
49.28

Supernus Pharmaceuticals reported $107.8M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
ANI Pharmaceuticals USD 69.8M 15.23M Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025